Zu Produktinformationen springen
1 von 1

CPSR for Face Care (Including Facial & eye serums, facial oils, tonics, cosmetic waters)

CPSR for Face Care (Including Facial & eye serums, facial oils, tonics, cosmetic waters)

Normaler Preis £84.00
Normaler Preis Verkaufspreis £84.00
Sale Ausverkauft

+ 20% VAT Per Product Added On Checkout

Have Questions?

Speak with our compliance experts.

Connect Now
Anzahl
Secure Payment
24–72h Delivery
100% Confidential
Expert Support
Vollständige Details anzeigen

Introduction

Facial skincare typically carries a higher concentration of active ingredients than body products, and sits closer to the eyes and mucous membranes. Your cosmetic product safety report applies the tighter irritancy and photosensitisation threshold this area requires, alongside a careful review of any active ingredient's concentration and stability.

What Your CPSR Assesses

  • Full ingredient toxicological review against Annex II, III and V, applying the tighter facial-area irritancy threshold
  • Active ingredient concentration and stability assessment, relevant to serums with higher active loads
  • Carrier oil oxidative stability review for facial oils
  • Eye-area exposure consideration for eye serums specifically, at a more conservative concentration ceiling
  • Fragrance and essential oil allergen screening against Annex III and current IFRA Standards

Who This Is For

Skincare brands producing facial and eye serums, facial oils, toning waters or cosmetic tonics. Every cosmetic product in the UK or EU requires this assessment as a legal requirement before sale.

Why Brands Choose Spectra Cosmetic Compliance

  • Signed by a qualified Safety Assessor under Article 10(2), Regulation (EC) No 1223/2009 recognised across the UK and EU, applying SCCS methodology.
  • Regulator-ready, or we revise it at no charge our compliance guarantee.
  • PIF-ready your report slots directly into your Product Information File, no reformatting required.
  • Clear turnaround options standard delivery in 3-5 working days, with 48-hour and 24-hour priority options available. (Subjected to the 100% provision of documents).
  • Trusted by cosmetic and fragrance brands across the UK, EU, US, Middle East and Asia.

Your CPSR Deliverables

Your completed cosmetic product safety report is supplied ready for inclusion in the PIF, to the Annex I specification, in two parts:

Part A — Cosmetic Product Safety Information

  • Quantitative and qualitative formulation data
  • Physico-chemical characteristics and stability over time
  • Microbiological quality
  • Impurities, traces and packaging material
  • Exposure and toxicological profile of the ingredients

Part B — Cosmetic Product Safety Assessment

  • The Safety Assessor's conclusion
  • Margin of Safety calculations
  • Conditions of use and labelling
  • A signed compliance statement by a qualified assessor

Plus a digital compliance certificate confirming your product meets UK/EU cosmetic safety law. A Safety Data Sheet (SDS) of finished product provided alongside your CPSR as complimentary support (SDS of finished product is FREE with CPSR order).

Legal Framework

  • Article 3 and Annex I, Regulation (EC) No 1223/2009
  • Schedule 34, Product Safety and Metrology etc. (Amendment etc.) (EU Exit) Regulations 2019 (SI 2019/696)
  • Annex III and V allergen and preservative restrictions
  • SCCS Notes of Guidance facial and ocular-proximity exposure methodology

How It Works

  1. Share your formulation send your full INCI list with percentages, raw-material SDS and product label artwork.
  2. We screen every ingredient each ingredient is checked against the relevant UK or EU Annexes and current SCCS guidance.
  3. We complete the assessment a qualified Safety Assessor prepares and signs CPSR Parts A & B and builds your PIF-ready documentation.
  4. You receive your file your signed CPSR and supporting documentation are delivered within your chosen turnaround window.
  5. Delivery options: Standard (3-5 working days, included) | Fast (48 hours) | Priority (24 hours)

Facial products are typically higher in active-ingredient concentration and applied closer to the eyes, which triggers a tighter irritancy and photosensitisation threshold.

Yes — eye-area products are assessed against the more conservative ocular-proximity threshold used across all eye-area cosmetics.

No — active ingredients at elevated concentrations are specifically reviewed for stability and safe exposure limits as part of the assessment.

The ingredient screening is the same in principle, though tonics are typically simpler, lower-active formulations with a different stability profile.

Broadly similar, with added attention to facial-area irritancy and eye-proximity given the smaller, more sensitive application area.

This is a claims-substantiation question separate from the CPSR; we can flag where wording risks crossing into a medicinal or unsubstantiated efficacy claim.